| Literature DB >> 31933606 |
Muhammad Amin Chinoy1, Salman Javed2.
Abstract
OBJECTIVE: To determine the frequency of vertebral fractures in patients presenting with hip fractures.Entities:
Keywords: Hip fracture; Vertebral fractures; morbidity
Year: 2020 PMID: 31933606 PMCID: PMC6943115 DOI: 10.12669/pjms.36.ICON-Suppl.1709
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Descriptive statistics of the enrolled patients.
| Mean ± SD | 63.6 ± 12.7 |
| Min-Max | 40 – 85 |
| Median (IQR) | 65(55 - 73) |
| Male | 146 (43.6) |
| Female | 189 (56.4) |
| Intertrochanteric fracture | 142 (42.4) |
| Neck of femur fracture | 165 (49.3) |
| Sub trochanteric femur fracture | 28 (8.4) |
| No | 258 (77) |
| Yes | 77 (23) |
| Cancer | 6 (1.8) |
| CVA | 16 (4.8) |
| Diabetes | 55 (16.4) |
| Hepatitis C | 6 (1.8) |
| HTN | 79 (23.6) |
| IHD | 11 (3.3) |
| TB | 3 (0.9) |
| CKD | 4 (1.2) |
| Other | 11 (3.3) |
| None | 203 (60.6) |
| Antihypertensive | 72 (21.5) |
| Aspirin | 12 (3.6) |
| Insulin | 6 (1.8) |
| Oral Hypoglycemic | 44 (13.1) |
| Steroids | 3 (0.9) |
| Other | 16 (4.8) |
| Compression fracture | 73 (96.1) |
| Translation fracture | 4 (6.6) |
Differences in age between genders, type of hip fractures and vertebral fracture.
| Mean ± SD | Min-Max | Median (IQR) | P-value | |
|---|---|---|---|---|
| Male | 61.4 ± 13 | 40 - 85 | 62.5(50 - 71) | 0.009 |
| Female | 65.3 ± 12.2 | 40 - 85 | 66(56 - 75) | |
| Intertrochanteric fracture | 67.5 ± 12.4 | 40 - 85 | 70(60 - 79) | 0.000 |
| Neck of femur fracture | 61.6 ± 12 | 40 - 85 | 61(52.5 - 70) | |
| Sub trochanteric femur fracture | 55.4 ± 11.5 | 40 - 74 | 55(45 - 66.5) | |
| Yes | 61.5 ± 12.5 | 40 - 85 | 62(50 - 70) | 0.000 |
| No | 70.5 ± 10.9 | 40 - 85 | 72(62 - 80) | |
P-value<0.05,
P-value<0.0001,
Mann-whitney U test,
Kruskal Wallis test.
Distribution of vertebral fracture according to gender, type of hip fractures, age groups and comorbid.
| Vertebral fractures | ||||
|---|---|---|---|---|
| No | Yes | Total | p-value | |
| N (%) | N (%) | N (%) | ||
| Male | 116 (79.5) | 30 (20.5) | 146 (100) | 0.351 |
| Female | 142 (75.1) | 47 (24.9) | 189 (100) | |
| Total | 258 (77) | 77 (23) | 335 (100) | |
| Intertrochanteric fracture | 96 (67.6) | 46 (32.4) | 142 (100) | 0.002 |
| Neck of femur fracture | 137 (83) | 28 (17) | 165 (100) | |
| Sub trochanteric femur fracture | 25 (89.3) | 3 (10.7) | 28 (100) | |
| Total | 258 (77) | 77 (23) | 335 (100) | |
| < 65 years | 139 (86.3) | 22 (13.7) | 161 (100) | 0.000 |
| > 65 years | 119 (68.4) | 55 (31.6) | 174 (100) | |
| Total | 258 (77) | 77 (23) | 335 (100) | |
| Cancer | 4 (66.7) | 2 (33.3) | 6 (100) | 0.049 |
| CVA | 11 (68.8) | 5 (31.3) | 16 (100) | |
| Diabetes | 44 (80) | 11 (20) | 55 (100) | |
| Hepatitis C | 2 (33.3) | 4 (66.7) | 6 (100) | |
| HTN | 64 (81) | 15 (19) | 79 (100) | |
| IHD | 9 (81.8) | 2 (18.2) | 11 (100) | |
| Other | 9 (81.8) | 2 (18.2) | 11 (100) | |
| TB | 2 (66.7) | 1 (33.3) | 3 (100) | |
| CKD | 1 (25) | 3 (75) | 4 (100) | |
| Antihypertensive | 58 (80.6) | 14 (19.4) | 72 (100) | 0.217 |
| Aspirin | 9 (75) | 3 (25) | 12 (100) | |
| Insulin | 3 (50) | 3 (50) | 6 (100) | |
| Oral Hypoglycemic | 38 (86.4) | 6 (13.6) | 44 (100) | |
| Other | 12 (75) | 4 (25) | 16 (100) | |
| Steroids | 1 (33.3) | 2 (66.7) | 3 (100) | |
P-value<0.05,
P-value<0.0001, Chi-square test